Annual report pursuant to Section 13 and 15(d)

PARENT COMPANY FINANCIALS. (Details 2)

v3.19.1
PARENT COMPANY FINANCIALS. (Details 2) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating Activities:                      
Net income (loss) $ (32,010) $ (7,514) $ (12,908) $ (7,841) $ (13,285) $ (202) $ (8,841) $ (12,636) $ (60,273) $ (34,964) $ 1,419
Adjustments to reconcile net income (loss) to cash provided by operating activities:                      
Fair value adjustments                 (473) 557
Deferred income taxes                 27 169 (1,122)
Amortization of debt discounts                 720 636 2,322
Changes in operating assets and liabilities:                      
Accounts receivables                 12,663 17,562 (25,235)
Other assets                 191 6,738 (3,973)
Accounts payable and accrued expenses                 4,105 (5,538) 9,279
Net cash provided by operating activities                 1,566 36,509 37,228
Investing Activities:                      
Additions to property and equipment                 (15,154) (20,866) (19,171)
Net cash used in investing activities                 (15,154) (50,440) (14,597)
Financing Activities:                      
Proceeds from issuances of senior notes                 13,530 53,350
Proceeds from issuance of common stock                 2,057
Proceeds from warrant stock option exercises                 1,202 1,164
Net cash used in financing activities                 (9,274) (839) (9,922)
Net increase (decrease) in cash and cash equivalents                 (22,862) (14,770) 12,709
Cash and cash equivalents at beginning of period       49,489       64,259 49,489 64,259 51,550
Cash and cash equivalents at end of period 26,627       49,489       26,627 49,489 64,259
Parent Company [Member]                      
Operating Activities:                      
Net income (loss)                 (60,273) (34,964) 1,419
Adjustments to reconcile net income (loss) to cash provided by operating activities:                      
Equity in losses of subsidiaries                 52,399 28,346 5,137
Dividends from subsidiaries                 25,000 3,500
Depreciation                 567 830 727
Fair value adjustments                 (473) 557
Deferred income taxes                 27 169 (1,122)
Amortization of debt discounts                 720 636 10
Changes in operating assets and liabilities:                      
Accounts receivables                 (9,018) 4,065 7,302
Other assets                 100 4,356 4,647
Accounts payable and accrued expenses                 740 3,859 (3,741)
Accounts payable with subsidiaries                 2,409 (943) (9,385)
Net cash provided by operating activities                 12,671 9,381 5,551
Investing Activities:                      
Additions to property and equipment                 (18) (468) (465)
Investments in subsidiaries                 (10,000) (28,126) (50,886)
Purchase of PE OP Co. debt                 (17,003)
Net cash used in investing activities                 (10,018) (28,594) (68,354)
Financing Activities:                      
Proceeds from issuances of senior notes                 13,530 53,350
Proceeds from issuance of common stock                 2,057
Proceeds from warrant stock option exercises                 1,202 1,164
Payments on senior notes                 (2,000)
Preferred stock dividend payments                 (1,265) (1,265) (1,269)
Net cash used in financing activities                 (1,208) 13,467 53,245
Net increase (decrease) in cash and cash equivalents                 1,445 (5,746) (9,558)
Cash and cash equivalents at beginning of period       $ 5,314       $ 11,060 5,314 11,060 20,618
Cash and cash equivalents at end of period $ 6,759       $ 5,314       $ 6,759 $ 5,314 $ 11,060